LansionBio - cTnI/CK-MB/Myo Test Kit (Dry Fluorescence Immunoassay)

cTnI /CK-MB/Myo Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of cTnI /CK-MB/Myo (Cardiac Troponin I/ Creatine Kinase Isozyme/Myoglobin ) in human serum . cTnI is used as an aid in the diagnosis of myocardial injury such as Acute Myocardial Infarction (AMI),Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS). CK-MB is an important indicator for the diagnosis of acute myocardial infarction (AMI), which is secreted into the blood in large quantities during the attack.CK-MB began to rise 3-6h when AMI symptoms occur, and reached the peak value after 12-24h. If there were no complications, the level of CK-MB in the blood would be restored to the normal level after 3d; if there were complications, the level of CK-MB in the blood would remain high and not decrease. If AMI occurs again, the CK-MB that has declined will rise again. CK-MB measurement can also be used as a non-invasive evaluation index for myocardial reperfusion after thrombolytic therapy. Myo can be used as the most sensitive index in the early diagnosis of acute myocardial infarction (AMI).